Suanfarma, a life science company specializing in fermentation and chemical synthesis, has restructured with a new division of the company specific to its portfolio of nutraceuticals, called Suannutra, in order to increase its focus on customers and support sustained growth.
 
The company will utilize its core brands of Gonmisol, Monteloeder, and Suanfarma USA in order to grow its branded ingredients. Suannutra has 1,400 active customers in 50 countries, and a network in Europe, the U.S., and Asia.
 
“I’m very happy to join the excellent team of SUANNUTRA,” said Anthony Weston, CEO of Suannutra. “Together, we will enhance our presence in the global nutraceuticals market through our science-backed product line, new innovations and exciting partnerships and collaborations.”
 
“We are excited to welcome Anthony Weston as the new CEO of Suannutra, effective June 5^th,” said Francisco Fernández, who will continue to lead Suanfarma. “Suanfarma has full confidence in Anthony’s inspiring leadership, strategic vision, and ability to overcome challenges, to lead Suannutra to new levels of success.”
 
Weston has a background in global business management and leadership, and most recently worked at Frutarom and IFF.